2019
DOI: 10.1186/s13000-019-0870-9
|View full text |Cite
|
Sign up to set email alerts
|

Primary hyaline vascular Castleman disease of the kidney: case report and literature review

Abstract: Background Castleman’s disease (CD) is an uncommon type of benign proliferation of the lymphoid tissue, characterized by local or systemic lymphadenopathy that most frequently appears in the mediastinum; involvement of the kidney is uncommon, and proliferation originating from the kidney is extremely rare. Herein, we report a rare case of hyaline vascular Castleman’s disease (HV-CD) in a 56-year-old male patient and discuss its morphological characteristics and differential diagnoses including man… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
12
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(14 citation statements)
references
References 25 publications
1
12
0
1
Order By: Relevance
“…CD rarely affects extrathoracic presentations, with even fewer presentations in the renal sinus. To the best of our knowledge, only a few cases have been reported (8)(9)(10)(11)(12)(13)(14)(15)(16). The clinicopathological features of the reported cases are shown in Table 1.…”
Section: Discussionmentioning
confidence: 99%
“…CD rarely affects extrathoracic presentations, with even fewer presentations in the renal sinus. To the best of our knowledge, only a few cases have been reported (8)(9)(10)(11)(12)(13)(14)(15)(16). The clinicopathological features of the reported cases are shown in Table 1.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, radiation therapy can be considered in those unsuitable for surgery (30). Contrastingly, surgery is insu cient for the management of MCD with lower overall survival rate than UCD (21,31). The management of MCD is mainly based on glucocorticoids, chemotherapy, antiretroviral therapy, and monoclonal antibody therapy targeting IL-6 (30).…”
Section: Discussionmentioning
confidence: 99%
“…La enfermedad de Castleman constituye un raro trastorno linfoproliferativo que fue descrito por primera vez hace más de 60 años como una masa benigna y localizada (6). Desde el punto de vista clínico esta enfermedad ha sido dividida en dos subtipos: EC unicéntrica (ECU) y EC multicéntrica (ECM).…”
Section: Discussionunclassified